echemi logo
web-logo
slogan
homepage
Product
  • Product
  • Supplier
  • Inquiry

    My ECHEMI

    EN

    Home > Medical News > Medical Research Articles > Ascentage Pharma's MDM2-p53 Inhibitor APG-115 Receives U.S. FDA Approval for Rare Disease in Children for the Treatment of Neuroblastoma

    Ascentage Pharma's MDM2-p53 Inhibitor APG-115 Receives U.S. FDA Approval for Rare Disease in Children for the Treatment of Neuroblastoma

    • Last Update: 2022-04-23
    • Source: Internet
    • Author: User
    Tags

    zetia drug

    bayer advanced all
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com